This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
San Diego-based venture investment fundAvalon Ventures has made a seed investment in a developer of a social shopping service, LoopIt , according to the companies. Size of the funding was not announced. Avalon's Rich Levandov was involved in the investment. LoopIt is based in Cambridge, Mass.,
San Diego-based venture investor Avalon Ventures has scored an exit this morning, after IBM said it has acquired Boston-based Cloudant , a developer of a NoSQL-based, cloud-based database. in funding. in funding. Financial terms of the buy were not disclosed. READ MORE>>.
San Diego-based venture investor Avalon Ventures is the lead investor in a round for a developer of cloud-based, business collaboration software today. The company says it has now raised $7M for the company, including an earlier seed funding. Avalon''s Rich Levandov was involved in the funding effort. READ MORE>>.
San Diego-based venture capital firm Avalon Ventures has led an investment in a cloud computing company, Standing Cloud , based in Boulder, Colorado. According to Standing Cloud, it received a $3M, Series B financing from Avalon, which also included the firm's prior investor, The Foundry Group.
La Jolla-based venture capital investor Avalon Ventures is the lead in a round for cloud data storage firm TwinStrata , TwinStrata said today. TwinStrata, which is based in Masachusetts, said that Avalon lead its Series B funding round, which was worth $8M. Avalon's investment in TwinStrata was headed by Rich Levandov.
San Diego-based venture investor Avalon Ventures has backed a developer of video advertising products, Selectable Media , to the tune of $2M. Selectable Media, which is based in New York, lets users opt into branded video advertising in exchange for free access to content on web and mobile apps. READ MORE>>.
La Jolla-based Avalon Ventures is the lead investor in the Series A round for Averon , a developer of mobile identity verification software this week. in a Series A funding. Avalon's Rich Levandov and Brady Borhmann both join Averon's board with the funding round. READ MORE>>.
San Diego-based Carolus Therapeutics , a developer of biopharmaceuticals aimed at treating acute and chronic inflammation, has scored $2.25M in a debt funding round, according to financing provider Square 1 Bank. According to Square 1, the new funding will go support future growth at Carolus. READ MORE>>.
San Diego-based venture investor Avalon Ventures is the lead investor in a new, $10M funding round for AeroFS , a developer of private cloud collaboration software. AeroFS said the Series B funding also included NHN Investment. Avalon's Rich Levandov represents Avalon Ventures on the AeroFS board.
San Diego-based Avalon Ventures said this morning that it has launched and funded three, new companies as part of its deal with GSK. Avalon Venturs said that Adrenergics , CadheRx Therapeutics , and Calporta Therapeutics have all received $10M in Series A funding, and will receive R&D support from Avalon Ventures and GSK.
La Jolla-based venture investor Avalon Ventures is the lead investor in a round for San Francisco-based Averon , a developer of mobile identity verification software. Averon said today that it has raised $5M in a Series A funding round. Avalon Ventures' investment was managed by Brady Bohrmann. READ MORE>>.
San Diego-based biopharmaceuticals developer Otonomy --which is developing treatments for inner and middle ear disorders--has roped in a big, $49M funding, the company announced this morning. The company said the new funding will go towards its product pipeline and a potential filing for regulatory approval of its lead compound.
San Diego-based AristaMD , a developer of telehealth software, which allows primary care providers to conduct and document electronic medical consultations, has raised $18M in a Series B funding round. The company said the funding will go to towards accelerating expansion of its platform across the country. READ MORE>>.
San Diego-based Otonomy , a firm developing products to treat disorders of the inner and middle ear, looks to have pulled in $14.2M In the filing, the firm said the new funding came on May 18th. more in a tranched financing which was originally announced last August, according to a regulatory filing by the firm this week. out of a $38.8M
San Diego-based StackIQ , which develops IT automation tools for the enterprise, has raised $6M in a Series B funding round, according to the company. The new funding came from Grayhawk Capital, Keshif Ventures, DLA Piper, and OurCrowd, as well as Anthem Venture Partners and Avalon Ventures. READ MORE>>.
San Diego-based Otonomy , a biopharmaceuticals firm developing products to treat disorders of the inner and middle ear, announced today that it has raised $38.5M The round was led by Novo Ventures and RiverVest Venture Partners, and also includes Domain Associates, TPG Biotech, and Avalon Ventures. in a Series B financing.
San Diego-based Avelas Biosciences has raised $7.65M in a Series A funding round, which it says will go towards clinical studies for its technology for real-time tumor visualization. The funding came from Avalon Ventures. Avelas is developing technology for visualizing cancerous lymph nodes in breast cancer patients.
The biggest investments for the quarter were for Culver City-based NantHealth , the digital health venture of billionaire Dr. Patrick Soon-Shiong, which raised $135M in a funding; El Segundo-based Prodege (aka Swagbucks), which raised $60.1M for San Diego''s Veredezyne , which is developing biofuels and biochemicals processes.
San Diego-based Avelas Biosciences announced today that it has raised $6.85M in a Series B funding round, for the company''s technology for illuminating cancer cells. The company said the funding came from Avalon Ventures, and also included Torrey Pines Investment, WuXi AppTec, and an additional, un-named investor. READ MORE>>.
San Diego-based Otonomy , a biopharmaceuticals firm developing drug therapies to treat inner and middle ear disorders, has raised $10.56M as part of an ongoing, $26.0M fundraising effort, according to a regulatory filing by the firm.
San Diego-based telemedicine and telehealth software developer AristaMD has added another $6M to the company's Series B, bringing the total to $24M, the company said on Monday. The funding came from Ascension Ventures and.406 The funding came from Ascension Ventures and.406 The company is led by CEO Brooke LeVasseur.
San Diego-based E-Band Communications , a developer of millimeter-wave wireless transmission systems, said Wednesday that the firm has raised a Series C financing round. Amount of the funding was not disclosed by the firm. According to E-Band, the round was led by Hercules Technology Growth Capital, and also included Avalon Ventures.
San Diego-based Chumby , which had developed Internet-connected, alarm-clock like devices and similar technology, has shut down, according to a report Friday. The firm had raised on the order of $25M in funding for its efforts. READ MORE>>.
San Diego-based Amira Pharmaceuticals , a developer of small molecule pharmaceuticals for treating inflammatory and fibrotic diseases, has agreed to be acquired by Bristol-Myers Squibb , the firms said late Thursday. Amira Pharmaceuticals was venture backed by Avalon Ventures, Novo A/S,Prospect Venture Partners, and Versant Ventures.
San Diego-based Avelas Biosciences , which is developing cell penetrating peptides to light up cancerous tissue in patients during surgery, has raised $7.4M in a Series B funding. The second tranche of the company''s Series B came from investors Avalon Ventures, Torrey Pines Investment and WuXi PharmaTech Investments.
San Diego-based Chumby , the maker of the Internet-connected, Linux-based clock radio, has upped its Series B funding to $8.78M, according to a regulatory filing from the firm this week. Chumby develops a Wi-Fi enabled, Internet device which acts both as a clock as well as a connection into internet services like Weather, news, and more.
in a Series C, equity funding. According to the company, the funding was led by OrbiMed Advisors, and also included Aperture Venture Partners, Osage University Partners, as well as Avalon Ventures, Domain Associates, Novo Ventures, RiverVest Venture Partners and TPG Biotech. READ MORE>>.
in funding, according to a regulatory filing by the firm Monday. According to the filing, the funding came in the form of debt and warrants, most likely a convertible debt round. Source of the new funding was not disclosed. San Diego-based Chumby , maker of the alarm-clock sized, Internet device, has raised another $3.0M
San Diego-based aFraxis , a stealth-mode firm developing treatments for Fragile X Syndome and autism, has raised $750,000 in a funding round, according to a regulatory filing by the firm Tuesday. Details on the funding have not been announced, however, the company is venture backed by Avalon Ventures.
San Diego-based Awarepoint , which develops real-time, location systems used for tracking patents and assets in a healthcare environment, said today that it has raised $14M in an additional financing round. HHIF will add a representative to Awarepoint's board with the funding. HHIF contributed $7.5M
San Diego-based AnaptysBio , a biopharmaceuticals firm focused on the development of therapeutic antibodies, announced a deal today with TESARO. According to AnaptysBio, it will receive an upfront license fee of $17M from TESARO, plus receive funding of costs incurred in related development programs, as part of an antibody program.
San Diego-based Otonomy , which is developing treatments for Meniere's disease, said today that it has raised $10M in a Series A financing round. The round came from Avalon Ventures. Otonomy is headed by Jay Lichter, who is also a managing director at Avalon Ventures. READ MORE>>.
San Diego-based Proximal Data , a developer of storage caching software aimed at use with virtualized systems, has been acquired by Samsung Electronics , Samsung said today. Proximal Data was venture backed by Divergent Ventures and Avalon Ventures, and had only announced around $5M in funding.
San Diego-based Proximal Data , which develops serve-side caching software for accelerating I/O access to virtualized machines, said this morning that it has raised $2M in a Series B round of funding. The funding came from Divergent Ventures, along with existing investors Avalon Ventures.
San Diego-based Fortis Therapeutics, a biotechnology startup developing treatments for late-stage prostate cancer and multiple myeloma, has raised $40M in a Series A financing, the company said on Monday.
The biggest deal for the quarter was for Venice-based photo messaging app developer Snapchat , which raised a huge, $60M funding round in the quarter. Orange County was second, with $161.9M invested across 17 deals; San Diego was third, with $147.75M in 18 deals.
San Diego-based Fortis Therapeutics , a new biotech company in the immuno-oncology area, announced this morning that it has raised $18M in a Series A funding. The funding was led by Avalon Ventures and also included Bregua Corporation, Lilly Asia Ventures, Osage University Partners, and Vivo Capital. READ MORE>>.
San Diego-based biopharmaceuticals developer Avelas Biosciences has raised $20M in a Series C funding, according to the company. The new funding was led by Pharmstandard International, S.A., Avelas Biosciences is developing treatments for cancer. Avelas Biosciences is developing treatments for cancer.
San Diego-based Ambit Biosciences , a developer of small molecule profiling tools being used for biopharmaceuticals development, has raised $6.5M Tags: ambit biosciences venture capital debt funding biopharmaceuticals lifescience. in an ongoing, debt round, according to a filing from the firm today.
San Diego-based Synthorx , a developer of protein therapeutics technology, said it has raised $10M in a Series B financing this morning. The funding was led by RA Capital Management, and also included Avalon Ventures and Correlation Ventures. RA Capital Management's Andrew Levin joins the company's board with the funding.
La Jolla-based Ankasa Regenerative Therapeutics , a company developing stem-cell based products aimed at organ and tissue regrowth, repair, and healing, has raised $8.5M in a Series A funding, the company said this morning. The funding was led by Avalon Ventures, and also included Hereaus Medical and Correlation Ventures.
San Diego-based biotechnology developer Synthorx announced today that it has named Patrick J. Synthorx is focused on developing novel protein therapeutics, and is venture backed by RA Capital Management, Avalon Ventures and Correlation Ventures. The company announced a funding round in July. READ MORE>>.
San Diego-based Awarepoint, a developer of systems for tracking assets and patients in hospitals, has raised $13.3M in a Series D funding. The firm said the round was led by Cardinal partners, and also included Venrock and prior investor Avalon Ventures. READ MORE>>
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content